[Treatment of patients with chronic hepatitis C who have not been previously treated]

Gastroenterol Clin Biol. 2002 Apr:26 Spec No 2:B194-201.
[Article in French]
No abstract available

Publication types

  • Comparative Study
  • Consensus Development Conference
  • Review

MeSH terms

  • Antiviral Agents / administration & dosage
  • Antiviral Agents / adverse effects
  • Antiviral Agents / therapeutic use
  • Controlled Clinical Trials as Topic
  • Drug Administration Schedule
  • Drug Therapy, Combination
  • Follow-Up Studies
  • Genotype
  • Hepacivirus / genetics
  • Hepatitis C, Chronic / drug therapy*
  • Humans
  • Interferon-alpha / administration & dosage
  • Interferon-alpha / adverse effects
  • Interferon-alpha / therapeutic use
  • Placebos
  • Polyethylene Glycols
  • Prognosis
  • RNA, Viral / blood
  • Ribavirin / administration & dosage
  • Ribavirin / therapeutic use
  • Time Factors

Substances

  • Antiviral Agents
  • Interferon-alpha
  • Placebos
  • RNA, Viral
  • Polyethylene Glycols
  • Ribavirin